A.P. Møller - Mærsk A/S
Transactions in connection with share buy-back program
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
On 30 November 2020, A.P. Møller - Mærsk A/S (the Company) announced first phase of a share buy-back program in compliance with the EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The share buy-back program of up to DKK 10bn is to be executed during a 15-month period beginning 1 December 2020.
During the first phase of the program running from 1 December 2020 up to 29 April 2021, the Company will buy-back A and B shares for an amount of up to DKK 3.3bn.
The following transactions have been made under the program in the period 25 January 2021 to 29 January 2021:
Number of A shares | Average purchase price A shares, DKK | Transaction value, A shares, DKK | |
Accumulated, last announcement (market and A.P. Møller Holding A/S) | 17,280 | 221,565,528 | |
25 January 2021 | 250 | 12,853.1600 | 3,213,290 |
26 January 2021 | 240 | 12,290.5417 | 2,949,730 |
27 January 2021 | 250 | 11,445.9600 | 2,861,490 |
28 January 2021 | 245 | 11,325.4694 | 2,774,740 |
29 January 2021 | 260 | 11,587.7308 | 3,012,810 |
Total 25-29 January 2021 | 1,245 | 14,812,060 | |
Bought from A.P. Møller Holding A/S* | 1,319 | 11,897.2370 | 15,692,456 |
Accumulated under the program (market and A. P. Møller Holding A/S) | 19,844 | 252,070,043 | |
Number of B shares | Average purchase price B shares, DKK | Transaction value, B shares, DKK | |
Accumulated, last announcement (market and A.P. Møller Holding A/S) | 69,130 | 951,657,269 | |
25 January 2021 | 1,250 | 13,934.8960 | 17,418,620 |
26 January 2021 | 1,200 | 13,289.4250 | 15,947,310 |
27 January 2021 | 1,200 | 12,424.9750 | 14,909,970 |
28 January 2021 | 1,285 | 12,390.3035 | 15,921,540 |
29 January 2021 | 1,300 | 12,676.2731 | 16,479,155 |
Total 25-29 January 2021 | 6,235 | 80,676,595 | |
Bought from A.P. Møller Holding A/S* | 3,991 | 12,939.3095 | 51,640,784 |
Accumulated under the program (market and A. P. Møller Holding A/S) | 79,356 | 1,083,974,648 |
*) According to a separate agreement, A.P. Møller Holding A/S participates on a pro rata basis to the shares purchased in the share buy-back program.
With the transactions stated above, the Company owns a total of 128,714 A shares and 543,405 B shares as treasury shares, corresponding to 3.36% of the share capital.
Page 1 of 2
Details of each transaction are included as appendix.
Copenhagen, 1 February 2021
Contact persons:
Head of Investor Relations, Stig Frederiksen, tel. +45 3363 3106
Head of Media Relations, Signe Wagner, tel. +45 3363 1901
Page 2 of 2
Attachments
- Announcement - Transactions in connection with share buy-back program (week 4, 2021)
- Daily transactions in connection with share buy-back program - week 4
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Prosafe SE27.2.2021 14:08:54 CET | Press release
Prosafe SE: Safe Boreas to provide accommodation support at Buzzard
BW Offshore27.2.2021 11:01:34 CET | Press release
BW Offshore: Long-Term Incentive Programme new awards
Financière de Tubize SA27.2.2021 08:01:37 CET | Press release
Annual financial report 2020
Top Aces27.2.2021 01:59:03 CET | Press release
NOTICE TO DISREGARD - Top Aces Corp.
Brookfield Asset Management Inc26.2.2021 23:19:54 CET | Press release
Early Warning Release
CNH Industrial N.V.26.2.2021 22:31:33 CET | Press release
CNH Industrial N.V. announces the extension by one additional year to March 2026 of its syndicated credit facility
Genmab A/S26.2.2021 22:13:31 CET | Press release
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom